Comparison Overview
Accellacare
Accellacare
N/A
Last Update: 14/12/2025
Accellacare delivers clinical trial services to pharmaceutical, biotechnology, medical device industries. Accellacare extends across the globe with 112 active research sites in eight countries with expertise in a wide range of therapeutic areas. It has relationships wi...
Viatris
Pittsburgh, US
Last Update: 04/04/2026
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to ...
Compliance Ranges Comparison
Accellacare
Viatris
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Accellacare in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Viatris in 2026.
Incident History - Accellacare (X = Date, Y = Severity)
Accellacare cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Viatris (X = Date, Y = Severity)
Viatris cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Accellacare
Viatris
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.